Treace Medical Concepts Announces Q4 2024 Financial Results
Treace Medical Concepts: Upcoming Financial Results Announcement
Ponte Vedra, Florida — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI), is on the brink of presenting its financial results for the fourth quarter and the entire year of 2024. This highly anticipated announcement will take place after the market closes on a Thursday.
Details of the Conference Call
On the day of the announcement, Treace's management team will host a conference call starting at 4:30 PM ET. This event provides an excellent opportunity for interested investors and analysts to gain insights into the company’s performance and its direction moving forward.
How to Access the Conference Call
Those wishing to participate in the conference call are encouraged to register beforehand. Upon registering, attendees will receive specific dial-in information along with a unique pin that will allow them access to the call. Furthermore, a live and archived version of the webcast will be hosted on Treace's investor relations website, making it easier for those unable to attend the call live.
About Treace Medical Concepts
Treace Medical Concepts is a pioneering company in the medical technology sector, focusing on enhancing the treatment protocols for bunions and related midfoot deformities. This medical condition affects a significant portion of the population, and Treace estimates that around 67 million Americans are living with bunions, with 1.1 million of these individuals being potential candidates for surgical intervention each year.
Innovative Treatment Solutions
At the heart of Treace's product lineup is the Lapiplasty® 3D Bunion Correction® System. This advanced system encompasses a unique combination of instruments, surgical methods, and implants designed to address bunion issues from all angles. By correcting the deformity in three dimensions, Treace’s innovation addresses the underlying instability within the foot's joint, significantly improving patient's recovery times and overall quality of life. The company also championed the Adductoplasty® Midfoot Correction System, specifically tailored for patients suffering from midfoot deformities.
Continued Growth and Market Expansion
As Treace continues to expand its influence in the foot and ankle market, it has introduced the SpeedPlate™ Rapid Compression Implants. This innovative solution offers versatility across various surgical procedures, notably enhancing the efficiency of the Lapiplasty® and Adductoplasty® methods. By providing effective and efficient solutions, Treace aims to meet the increasing demands from patients in need of surgical corrections.
Community and Investor Engagement
Treace places a high value on communication with its stakeholders, routinely posting updates and significant information on its investor relations website at www.treace.com. The Company stresses the importance of keeping interested parties informed about its developments to foster a deeper understanding of its strategic direction.
Connect with Treace
For those wishing to learn more about Treace Medical Concepts and its innovative solutions, the company encourages connecting through various social media platforms. Engaging with Treace on LinkedIn, X, Facebook, and Instagram can provide deeper insights into the latest company developments, innovations, and community outreach efforts.
Contact Information
For direct inquiries, stakeholders can reach out via the following contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940
Investors:
Gilmartin Group
Vivian Cervantes
IR@treace.net
Frequently Asked Questions
What is Treace Medical Concepts known for?
Treace Medical Concepts specializes in innovative surgical treatments for bunions and midfoot deformities.
When will Treace announce its financial results for Q4 2024?
The financial results are set to be announced after market close on Thursday.
How can I listen to Treace's conference call?
Interested individuals can register to receive dial-in information for the conference call on the company's investor relations website.
What products does Treace offer?
Treace's flagship products include the Lapiplasty® and Adductoplasty® systems, designed for effective treatment of bunion deformities and midfoot issues.
How can I stay updated on Treace's news?
To stay informed, visit Treace's website and follow the company on social media platforms.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.